Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001147 · ClinicalTrials.gov registry record

Blood Sampling for Neurochemical and Genetic Testing

A clinical trial of Healthy and Hypertension, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
500
Enrollment target
1
Study location

NCT00001147 is a study of Healthy and Hypertension that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 500 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001147, a study of Healthy and Hypertension, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

This study involves sampling blood from both normal volunteers and patients with diseases known or suspected to involve body chemicals called catecholamines. The blood will be used to establish normal values for plasma levels of catecholamines and related neurochemicals; to test for abnormal neurochemical patterns in patients; and to establish a "bank" of DNA from normal volunteers and from patients to be used in future studies about possible alterations of catecholamine-related genes. Study participants will report to NIH after fasting overnight except for water or noncaloric, noncaffeinated beverages. They must not have taken Tylenol for at least 5 days. Blood will then be drawn. DNA will be extracted and stored in the freezer for future studies.

Study Locations (1)

Maryland

  • National Institute of Neurological Disorders and Stroke (NINDS) - Bethesda

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 1999-10
Est. Completion 2004-03

What the Registry Record Tells You About NCT00001147

The ClinicalTrials.gov registry entry for NCT00001147 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (23% lower). The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT00001147 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00001147 about?

NCT00001147 is a clinical study titled "Blood Sampling for Neurochemical and Genetic Testing". This study involves sampling blood from both normal volunteers and patients with diseases known or suspected to involve body chemicals called catecholamines. The blood will be used to establish normal values for plasma levels of catecholamines and related neurochemicals; to test for abnormal neuroch...

What is the current status of trial NCT00001147?

This trial is currently completed. The enrollment target is 500 participants. The study started on 1999-10. Estimated completion is 2004-03.

What conditions does trial NCT00001147 study?

This clinical trial studies the following conditions: Healthy, Hypertension, Pheochromocytoma, Autonomic Nervous System Disease.

Who is sponsoring clinical trial NCT00001147?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00001147 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.